{"id":69438,"date":"2026-04-10T12:48:12","date_gmt":"2026-04-10T07:18:12","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=69438"},"modified":"2026-04-10T12:48:14","modified_gmt":"2026-04-10T07:18:14","slug":"gland-pharma-up-16-in-1-month-is-this-injectable-drug-specialist-the-cdmo-play-the-market-has-been-overlooking","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/gland-pharma-up-16-in-1-month-is-this-injectable-drug-specialist-the-cdmo-play-the-market-has-been-overlooking\/","title":{"rendered":"Gland Pharma Up 16% in 1 Month \u2014 Is This Injectable Drug Specialist the CDMO Play the Market Has Been Overlooking?"},"content":{"rendered":"<p>Gland Pharma has risen 16% in one month, recovering from a prolonged period of underperformance \u2014 and investors in the injectable pharmaceutical space are sitting up and taking notice. This Fosun Pharma-backed company is one of the few Indian CDMO players with genuine FDA-compliant injectable manufacturing capability at scale.<\/p><p>This article covers every key reason behind Gland Pharma&#8217;s recent surge, what the data says about sustainability, the short-term and long-term share price targets for 2026, and what catalysts and risks investors need to monitor before making any decision.<\/p><p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Click Here 2013 Get Free Investment Predictions on Univest<\/strong><\/a>.<\/p><div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-up-16-in-1-month-is-this-injectable-drug-specialist-the-cdmo-play-the-market-has-been-overlooking\/#About_Gland_Pharma_NSE_GLAND\" title=\"About Gland Pharma (NSE: GLAND)\">About Gland Pharma (NSE: GLAND)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-up-16-in-1-month-is-this-injectable-drug-specialist-the-cdmo-play-the-market-has-been-overlooking\/#Why_Is_Gland_Pharma_Share_Price_Rising_The_Surge_Explained\" title=\"Why Is Gland Pharma Share Price Rising? The Surge Explained\">Why Is Gland Pharma Share Price Rising? The Surge Explained<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-up-16-in-1-month-is-this-injectable-drug-specialist-the-cdmo-play-the-market-has-been-overlooking\/#Financial_Performance_%E2%80%94_What_the_Numbers_Say\" title=\"Financial Performance \u2014 What the Numbers Say\">Financial Performance \u2014 What the Numbers Say<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-up-16-in-1-month-is-this-injectable-drug-specialist-the-cdmo-play-the-market-has-been-overlooking\/#Key_Catalysts_That_Could_Drive_Gland_Pharma_Share_Price_Higher\" title=\"Key Catalysts That Could Drive Gland Pharma Share Price Higher\">Key Catalysts That Could Drive Gland Pharma Share Price Higher<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-up-16-in-1-month-is-this-injectable-drug-specialist-the-cdmo-play-the-market-has-been-overlooking\/#Risks_to_Watch_Before_Chasing_the_Rally\" title=\"Risks to Watch Before Chasing the Rally\">Risks to Watch Before Chasing the Rally<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-up-16-in-1-month-is-this-injectable-drug-specialist-the-cdmo-play-the-market-has-been-overlooking\/#Technical_Setup_%E2%80%94_Is_the_Rally_Sustainable\" title=\"Technical Setup \u2014 Is the Rally Sustainable?\">Technical Setup \u2014 Is the Rally Sustainable?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-up-16-in-1-month-is-this-injectable-drug-specialist-the-cdmo-play-the-market-has-been-overlooking\/#Institutional_Positioning_and_Market_Sentiment\" title=\"Institutional Positioning and Market Sentiment\">Institutional Positioning and Market Sentiment<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-up-16-in-1-month-is-this-injectable-drug-specialist-the-cdmo-play-the-market-has-been-overlooking\/#Future_Outlook_%E2%80%94_Can_Gland_Pharma_Sustain_the_Rally\" title=\"Future Outlook \u2014 Can Gland Pharma Sustain the Rally?\">Future Outlook \u2014 Can Gland Pharma Sustain the Rally?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-up-16-in-1-month-is-this-injectable-drug-specialist-the-cdmo-play-the-market-has-been-overlooking\/#Gland_Pharma_Share_Price_Target_2026\" title=\"Gland Pharma Share Price Target 2026\">Gland Pharma Share Price Target 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-up-16-in-1-month-is-this-injectable-drug-specialist-the-cdmo-play-the-market-has-been-overlooking\/#Short-Term_Target_3-6_Months\" title=\"Short-Term Target (3-6 Months)\">Short-Term Target (3-6 Months)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-up-16-in-1-month-is-this-injectable-drug-specialist-the-cdmo-play-the-market-has-been-overlooking\/#12-Month_Analyst_Consensus_Target\" title=\"12-Month Analyst Consensus Target\">12-Month Analyst Consensus Target<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-up-16-in-1-month-is-this-injectable-drug-specialist-the-cdmo-play-the-market-has-been-overlooking\/#Long-Term_Target_FY27-FY28\" title=\"Long-Term Target (FY27-FY28)\">Long-Term Target (FY27-FY28)<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-up-16-in-1-month-is-this-injectable-drug-specialist-the-cdmo-play-the-market-has-been-overlooking\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-up-16-in-1-month-is-this-injectable-drug-specialist-the-cdmo-play-the-market-has-been-overlooking\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-up-16-in-1-month-is-this-injectable-drug-specialist-the-cdmo-play-the-market-has-been-overlooking\/#Q1_Why_did_Gland_Pharma_rise_16_in_1_month\" title=\"Q1. Why did Gland Pharma rise 16% in 1 month?\">Q1. Why did Gland Pharma rise 16% in 1 month?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-up-16-in-1-month-is-this-injectable-drug-specialist-the-cdmo-play-the-market-has-been-overlooking\/#Q2_What_is_Gland_Pharmas_share_price_target_2026\" title=\"Q2. What is Gland Pharma&#8217;s share price target 2026?\">Q2. What is Gland Pharma&#8217;s share price target 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-up-16-in-1-month-is-this-injectable-drug-specialist-the-cdmo-play-the-market-has-been-overlooking\/#Q3_What_does_Gland_Pharma_specialise_in\" title=\"Q3. What does Gland Pharma specialise in?\">Q3. What does Gland Pharma specialise in?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-up-16-in-1-month-is-this-injectable-drug-specialist-the-cdmo-play-the-market-has-been-overlooking\/#Q4_Who_owns_Gland_Pharma\" title=\"Q4. Who owns Gland Pharma?\">Q4. Who owns Gland Pharma?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-up-16-in-1-month-is-this-injectable-drug-specialist-the-cdmo-play-the-market-has-been-overlooking\/#Q5_What_is_Gland_Pharmas_current_market_cap\" title=\"Q5. What is Gland Pharma&#8217;s current market cap?\">Q5. What is Gland Pharma&#8217;s current market cap?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-up-16-in-1-month-is-this-injectable-drug-specialist-the-cdmo-play-the-market-has-been-overlooking\/#Recent_Article\" title=\"Recent Article\">Recent Article<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"About_Gland_Pharma_NSE_GLAND\"><\/span><strong>About Gland Pharma (NSE: GLAND)<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>[Click Here \u2013 Get Free Investment Predictions<\/strong><\/a> on Univest.<\/p><p>Gland Pharma is a leading company in the Pharma \/ Injectable CDMO space with a market capitalisation of Rs 26,000 Cr. The stock trades at approximately 28x trailing P\/E and has a 52-week range spanning from Rs 1,380 to Rs 2,100. The current price of Rs 1,580 reflects +16% appreciation 1 month, putting the stock significantly above its recent lows.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Why_Is_Gland_Pharma_Share_Price_Rising_The_Surge_Explained\"><\/span><strong>Why Is Gland Pharma Share Price Rising? The Surge Explained<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-image size-large\"><img fetchpriority=\"high\" decoding=\"async\" width=\"1024\" height=\"536\" src=\"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/10124447\/image-526-1024x536.jpeg\" alt=\"Gland Pharma Share Price Target\" class=\"wp-image-69439\" srcset=\"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/10124447\/image-526-1024x536.jpeg 1024w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/10124447\/image-526-300x157.jpeg 300w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/10124447\/image-526-768x402.jpeg 768w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/10124447\/image-526-900x471.jpeg 900w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/10124447\/image-526-600x314.jpeg 600w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/10124447\/image-526-150x79.jpeg 150w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/10124447\/image-526.jpeg 1200w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure><p>Gland Pharma share price data \u2014 surge, CMP, 12M target, sector | univest.in<\/p><p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Tap to Access Best Research Pieces on Univest<\/strong><\/a>.<\/p><p>Gland Pharma&#8217;s Q3 FY26 revenue of Rs 1,280 crore (+14% YoY) and PAT of Rs 218 crore (+22% YoY) showed that the US injectable generic market, which had been under pricing pressure, is beginning to stabilise. The company launched 18 new products in the US in Q3 FY26, the highest in any single quarter, and its complex injectable pipeline (emulsions, suspensions, lyophilised products) is gaining regulatory approvals ahead of schedule.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Financial_Performance_%E2%80%94_What_the_Numbers_Say\"><\/span><strong>Financial Performance \u2014 What the Numbers Say<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>The underlying financials confirm that the Gland Pharma share price surge is not just momentum \u2014 it is backed by improving fundamental performance.<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Metric<\/strong><\/td><td><strong>Latest Quarter<\/strong><\/td><td><strong>Change<\/strong><\/td><td><strong>What It Signals<\/strong><\/td><\/tr><tr><td>Revenue<\/td><td>Rs 1,280 Cr<\/td><td>+14% YoY<\/td><td>Top-line growth confirmation<\/td><\/tr><tr><td>Net Profit (PAT)<\/td><td>Rs 218 Cr<\/td><td>+22% YoY<\/td><td>Earnings acceleration<\/td><\/tr><tr><td>Market Cap<\/td><td>Rs 26,000 Cr<\/td><td>Current<\/td><td>Valuation context<\/td><\/tr><tr><td>Promoter Holding<\/td><td>58.0%<\/td><td>\u2014<\/td><td>Management confidence<\/td><\/tr><tr><td>FII Holding<\/td><td>14.6%<\/td><td>\u2014<\/td><td>Institutional interest<\/td><\/tr><\/tbody><\/table><\/figure><p>For live Gland Pharma fundamental data and peer comparison, check the <a href=\"https:\/\/univest.in\/screeners\"><strong>Univest Screener<\/strong><\/a>.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Key_Catalysts_That_Could_Drive_Gland_Pharma_Share_Price_Higher\"><\/span><strong>Key Catalysts That Could Drive Gland Pharma Share Price Higher<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><strong>\u2022 <\/strong>Complex injectable ANDA approvals \u2014 40+ products in pipeline<\/p><p><strong>\u2022 <\/strong>US FDA drug shortage list creating pricing power for legacy injectable generics<\/p><p><strong>\u2022 <\/strong>CDMO partnerships with global pharma for outsourced injectable manufacturing<\/p><p><strong>\u2022 <\/strong>Biosimilar injectable development for US and European markets<\/p><p><strong>\u2022 <\/strong>Hospital injectable market growing 12-15% annually with ageing demographics<\/p><p>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> for real-time alerts on Gland Pharma and daily SEBI-registered research.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Risks_to_Watch_Before_Chasing_the_Rally\"><\/span><strong>Risks to Watch Before Chasing the Rally<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><strong>\u2022 <\/strong>Fosun Pharma (China, 58% owner) creates regulatory and geopolitical risk in US market<\/p><p><strong>\u2022 <\/strong>FDA warning letter risk for injectable manufacturing requires zero-tolerance quality<\/p><p>Not every surge is sustainable. Investors should carefully evaluate each of these risks relative to their own risk tolerance and investment horizon before making any decision. Consult a SEBI-registered financial advisor.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Technical_Setup_%E2%80%94_Is_the_Rally_Sustainable\"><\/span><strong>Technical Setup \u2014 Is the Rally Sustainable?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Gland Pharma is trading at Rs 1,580, which puts the stock +16% above its recent low of Rs 1,380 and 25% below its 52-week high of Rs 2,100. The stock has reclaimed key moving averages and technical momentum indicators (RSI, MACD) are supportive in the short to medium term. Key resistance is at the 52-week high of Rs 2,100. Short-term support is at Rs 1,550.<\/p><p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Subscribe to Univest Pro for live technical analysis and SEBI-registered F&amp;O setups<\/strong><\/a>.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Institutional_Positioning_and_Market_Sentiment\"><\/span><strong>Institutional Positioning and Market Sentiment<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Gland Pharma&#8217;s shareholding reflects: Promoter 58.0%, FII 14.6%, DII 12.4%. FII ownership is moderate, meaning the stock is less sensitive to global risk-off selling than FII-heavy peers. The promoter holding above 50% indicates strong founder confidence in the business.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Future_Outlook_%E2%80%94_Can_Gland_Pharma_Sustain_the_Rally\"><\/span><strong>Future Outlook \u2014 Can Gland Pharma Sustain the Rally?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Gland Pharma at 28x P\/E is reasonable for a high-quality injectable CDMO with US FDA-compliant infrastructure. The 12-month target of Rs 1,900\u20132,200 implies 20-39% upside. Biosimilar injectable CDMO wins from global pharma would be a significant catalyst.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Gland_Pharma_Share_Price_Target_2026\"><\/span><strong>Gland Pharma Share Price Target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Subscribe to Univest Pro for Premium Stock Research and Targets<\/strong><\/a>.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Short-Term_Target_3-6_Months\"><\/span><strong>Short-Term Target (3-6 Months)<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>In the short term, Gland Pharma share price target is Rs 1,550\u20131,750 based on current technical positioning and the immediate momentum from the +16% 1 month surge. Support at Rs 1,550 must hold for the bullish case to remain intact.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"12-Month_Analyst_Consensus_Target\"><\/span><strong>12-Month Analyst Consensus Target<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>The analyst consensus 12-month Gland Pharma share price target is Rs 1,900\u20132,200, implying meaningful upside from the current price of Rs 1,580. This target assumes the catalysts identified in this article materialise and the macro environment remains broadly supportive.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Long-Term_Target_FY27-FY28\"><\/span><strong>Long-Term Target (FY27-FY28)<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>In a bull scenario where key catalysts deliver, the Gland Pharma share price target for FY28 is Rs 2,500\u20133,000. This long-term target represents a scenario where the company executes consistently and the sectoral tailwinds accelerate beyond current consensus expectations.<\/p><p>Track Gland Pharma live and compare with sector peers on the <a href=\"https:\/\/univest.in\/screeners\"><strong>Univest Screener<\/strong><\/a>.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Gland Pharma&#8217;s +16% surge 1 month is backed by improving fundamentals \u2014 revenue growth of +14% YoY and PAT growth of +22% YoY in the latest quarter. The 12-month analyst consensus target of Rs 1,900\u20132,200 implies significant further upside from the current price of Rs 1,580. The key catalysts and risks outlined in this article are the variables that will determine whether the rally extends or corrects. Investors should evaluate both carefully before making any position decision.<\/p><p>This article is for informational purposes only. Please conduct your own research and consult a SEBI-registered financial advisor before making any investment decisions.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q1_Why_did_Gland_Pharma_rise_16_in_1_month\"><\/span><strong>Q1. Why did Gland Pharma rise 16% in 1 month?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Gland&#8217;s 16% rally was driven by Q3 FY26 PAT +22% YoY, 18 new US product launches in Q3 (a quarterly record), US injectable market stabilisation, and pipeline approval momentum.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q2_What_is_Gland_Pharmas_share_price_target_2026\"><\/span><strong>Q2. What is Gland Pharma&#8217;s share price target 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Analyst consensus 12-month target is Rs 1,900\u20132,200. Short-term is Rs 1,550\u20131,750. Long-term bull case is Rs 2,500\u20133,000 for FY28.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q3_What_does_Gland_Pharma_specialise_in\"><\/span><strong>Q3. What does Gland Pharma specialise in?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Gland Pharma is a specialist injectable pharmaceutical manufacturer, producing vials, ampules, prefilled syringes, and lyophilised (freeze-dried) injectables for the US, Europe, and global markets.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q4_Who_owns_Gland_Pharma\"><\/span><strong>Q4. Who owns Gland Pharma?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Gland Pharma is majority owned by Fosun Pharma of China (58%). The company is listed in India (NSE: GLAND). Fosun&#8217;s China connection has been a source of investor concern regarding US market access.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q5_What_is_Gland_Pharmas_current_market_cap\"><\/span><strong>Q5. What is Gland Pharma&#8217;s current market cap?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Gland Pharma&#8217;s market cap is approximately Rs 26,000 crore. The stock is at Rs 1,580 with a 52-week range of Rs 1,380 to Rs 2,100.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Recent_Article\"><\/span><strong>Recent Article<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><a href=\"https:\/\/univest.in\/blogs\/tcs-share-price-target\">TCS Share Price Target 2026 \u2014 Key Factors, Financial Performance &amp; Analyst Forecast<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/nestle-india-share-price-target\">Nestle India Share Price Target 2026 \u2014 Key Factors, Financial Performance &amp; Analyst Forecast<\/a><\/p><p><a href=\"http:\/\/univest.in\/blogs\/state-bank-of-india-share-price-target\">State Bank of India Share Price Target 2026: Analyst Forecasts, Bull &amp; Bear Case<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/hindustan-unilever-share-price-target\">Hindustan Unilever Share Price Target 2026 \u2014 Key Factors, Financial Performance &amp; Analyst Forecast<\/a><\/p><p><\/p>","protected":false},"excerpt":{"rendered":"<p>Gland Pharma has risen 16% in one month, recovering from a prolonged period of underperformance \u2014 and investors in the injectable pharmaceutical space are sitting up and taking notice. This Fosun Pharma-backed company is one of the few Indian CDMO players with genuine FDA-compliant injectable manufacturing capability at scale. This article covers every key reason<\/p>\n","protected":false},"author":27,"featured_media":69440,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802],"class_list":["post-69438","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"metadata":{"_edit_lock":["1775805545:27"],"_last_editor_used_jetpack":["block-editor"],"rank_math_internal_links_processed":["1"],"amazonS3_cache":["a:4:{s:62:\"\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/04\/image-526.jpeg\";a:2:{s:2:\"id\";i:69439;s:11:\"source_type\";s:13:\"media-library\";}s:71:\"\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/04\/image-526-1024x536.jpeg\";a:2:{s:2:\"id\";i:69439;s:11:\"source_type\";s:13:\"media-library\";}s:94:\"\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/10124447\/image-526.jpeg\";a:2:{s:2:\"id\";i:69439;s:11:\"source_type\";s:13:\"media-library\";}s:103:\"\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/10124447\/image-526-1024x536.jpeg\";a:2:{s:2:\"id\";i:69439;s:11:\"source_type\";s:13:\"media-library\";}}"],"rank_math_primary_category":["842"],"rank_math_seo_score":["75"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"rank_math_title":["Gland Pharma Share Price Target 2026: Up 16% \u2014 Injectable Pharma CDMO Worth Backing?"],"rank_math_description":["Gland Pharma up 16% in 1 month. 14% revenue growth, 22% PAT growth, US injectable market share gains. Share price target 2026: Rs 1,900\u20132,200.\n"],"rank_math_focus_keyword":["Gland Pharma"],"_thumbnail_id":["69440"],"_edit_last":["27"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["7768"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/10124507\/gland-pharma-Share-Price-Target-2026.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/69438","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=69438"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/69438\/revisions"}],"predecessor-version":[{"id":69453,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/69438\/revisions\/69453"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/69440"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=69438"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=69438"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=69438"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}